On April 22, 2021, Current Health, the leading enterprise remote care management platform, announced that it has raised $43 million in Series B financing. The round was led by Northpond Ventures, with additional financing from LRVHealth, OSF HealthCare, Section 32, Elements Health Ventures, and existing investors. Wilson Sonsini Goodrich & Rosati advised Current Health on the transaction, in collaboration with the UK law firm Taylor Wessing.

The funding will support Current Health’s global expansion to serve as the “mission control” for all healthcare delivery outside of the hospital. The company’s platform is used by many of the world’s leading health systems, including Mount Sinai Health System, Geisinger Health, and the UK National Health Service, to monitor and manage patient care at home. It is also used by major pharmaceutical companies, such as AstraZeneca, to move delivery of complex therapy into the home and support home-based drug trials. The funding comes on the heels of 3,000+ percent growth in year-over-year revenue, making Current Health one of the fastest-growing healthcare companies.

The Wilson Sonsini team that advised Current Health on the financing included Michael Labriola, Daniel Glazer, Diviya Padman, and Doug MacKillop.

For additional information, please see Current Health’s press release.